The occurrence of multi-drug resistant tuberculosis has reached its highest ever level, according to a new report from the World Health Organization. The study, entitled Anti-Tuberculosis Drug Resistance in the World, is based on information collected between 2002 and 2006 from 90,000 TB patients in 81 countries around the world.
The report provides further evidence of the diseases' link to HIV with, for example, the recorded incidence of MDR-TB infection in Latvia and the Ukraine among HIV patients being around double that seen in the HIV-negative TB-infected population. In addition, the survey reveals that cases of extensively drug-resistant tuberculosis (XDR-TB), a virtually untreatable form of the disease, have been recorded in as many as 45 of the countries that participated.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze